I have a degree in biochemistry, and I started my scientific career studying the importance of Hypoxia inducible factor 1 (HIF-1), in terms of pharmacogenetics, for the development/proliferation of several types of solid tumours, such as breast and colorectal cancer. Since my main interests at the time were the influence of hypoxia in the regulation of carcinogenesis, I did my PhD at the University of Algarve and at the Karolinska institute with the main goal of understanding the role of hypoxia in the regulation of membrane drug transporters. During my PhD I used as biological models human blood samples and mice models. When I finished my PhD, I decided to work with a different model and also improve my knowledge about embryonic development. Thus, in 2011 I started as a post-doc at Gulbenkian Institute of Science (IGC) under the supervision of doctor Rui Martinho. From 2011 to 2016, studied the role of Protein N-terminal acetylation during drosophila embryonic development and carcinogenesis. In 2016, I decided I would like to work in medical health and I started the Integrated Master in Medicine at University of Algarve (MIM-UAlg) and became a medical doctor in 2019. Since January of 2021, im working as a medical doctor at the Centro Hospitalar Universitário do Algarve, Faro’s hospital.